Woodline Partners LP Hookipa Pharma Inc. Transaction History

Woodline Partners LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$2.33 - $5.94 $1.57 Million - $4.01 Million	-674,745 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$5.89 - $9.35 $1.34 Million - $2.12 Million	-226,857 Reduced 25.16%	674,745 $3.97 Million
Q2 2021 Aug 16, 2021	BUY	$9.16 - $19.51 $2.03 Million - $4.32 Million	221,342 Added 32.54%	901,602 $8.26 Million
Q1 2021 May 17, 2021	BUY	$10.64 - $14.7 $7.24 Million - $10 Million	680,260 New	680,260 $9.15 Million

677K

Ticker HOOK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,654,500
Market Cap $98.7M
Description
HOOKIPA Pharma Inc., a clinical stage biopharmaceutical company, develops immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform. The company's lead infectious disease product candidate is HB-101, which is in a randomized double-blinded Phase II clinical trial in patients awaiting kidney transpl...

Get notified when there are updates to the investment portfolio of Woodline Partners LP, based on Form 13F filings with the SEC.

Stay updated on Woodline Partners LP with notifications on news.